{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:51:54Z","timestamp":1791550314330,"version":"4.3.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ijmmb.2026.101292","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:25:44Z","timestamp":1789665944000},"page":"101292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Molecular signatures of concurrent mutations in drug resistant Mycobacterium tuberculosis: Association with treatment outcomes"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2651-0132","authenticated-orcid":false,"given":"Nikita","family":"Panwalkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1086-1440","authenticated-orcid":false,"given":"Zeba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9036-0568","authenticated-orcid":false,"given":"Aseem","family":"Rangnekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1419-498X","authenticated-orcid":false,"given":"Ram Prakash","family":"Punde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Pauranik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9543-6581","authenticated-orcid":false,"given":"Prabha","family":"Desikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijmmb.2026.101292_bib1","article-title":"Multi-drug resistance tuberculosis (MDR-TB) challenges in India: a review","volume":"15","author":"Vishwakarma","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101292_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/lungindia.lungindia_182_22","volume":"40","author":"Utpat","year":"2023","journal-title":"Lung India"},{"issue":"18","key":"10.1016\/j.ijmmb.2026.101292_bib3","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.2147\/IDR.S542287","article-title":"Genetic analysis of molecular mechanisms of drug resistance in Mycobacterium tuberculosis against four major first-line anti-tuberculosis drugs (Isoniazid, rifampin, Ethambutol, and pyrazinamide)","volume":"15","author":"Roshdi","year":"2025","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101292_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2991\/jegh.k.191215.003","article-title":"Second-line drug resistance characterization in Mycobacterium tuberculosis by genotype MTBDRsl assay","volume":"10","author":"Sethi","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.ijmmb.2026.101292_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmmb.2024.100701","article-title":"Trends of drug resistance in M. tuberculosis in a reference laboratory in Central India: forging ahead towards TB elimination","volume":"51","author":"Desikan","year":"2024","journal-title":"Indian J Med Microbiol"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101292_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.11599\/germs.2016.1096","article-title":"Frequency of mutations in rifampicin and isoniazid resistant isolates of M. tuberculosis: an analysis from Central India","volume":"6","author":"Desikan","year":"2016","journal-title":"Germs"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101292_bib7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ijmmb.2021.05.020","article-title":"Clinical implications of high-risk mutations in drug resistant tuberculosis (DR-TB): an observational cohort study","volume":"39","author":"Thampy","year":"2021","journal-title":"Indian J Med Microbiol"},{"issue":"6","key":"10.1016\/j.ijmmb.2026.101292_bib8","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3390\/medicina59061005","article-title":"Resistance profiles to second-line anti-tuberculosis drugs and their treatment outcomes: a three-year retrospective analysis from South India","volume":"59","author":"Gopalaswamy","year":"2023","journal-title":"Medicina"},{"issue":"5","key":"10.1016\/j.ijmmb.2026.101292_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04531-22","article-title":"Lineage classification and antitubercular drug resistance surveillance of Mycobacterium tuberculosis by whole-genome sequencing in Southern India","volume":"11","author":"Rao","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101292_bib10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41598-023-27516-4","article-title":"Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis","volume":"13","author":"Napier","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101292_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/trstmh\/trz121","article-title":"Burden of baseline resistance of Mycobacterium tuberculosis to fluoroquinolones and second-line injectables in central India","volume":"114","author":"Desikan","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijmmb.2026.101292_bib12","article-title":"Factors associated with unfavourable treatment outcomes among patients with Multidrug-resistant tuberculosis receiving outpatients care","volume":"5","author":"Vadakunnel","year":"2025","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.ijmmb.2026.101292_bib13","first-page":"41","article-title":"Predictors of tuberculosis treatment outcomes among a retrospective cohort in rural, Central India","volume":"3","author":"Laux","year":"2018","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.ijmmb.2026.101292_bib14","series-title":"WHO operational handbook on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update","year":"2022"},{"key":"10.1016\/j.ijmmb.2026.101292_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-22780-y","article-title":"Prevalence of comorbidities and their impact on prognosis among patients with rifampicin-resistant tuberculosis: a multicenter retrospective cohort study in China","volume":"15","author":"Zou","year":"2025","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.ijmmb.2026.101292_bib16","article-title":"The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study","volume":"5","author":"Nowinski","year":"2023","journal-title":"Front Public Health"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085726002513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085726002513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:55:50Z","timestamp":1791546950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085726002513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":16,"alternative-id":["S0255085726002513"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101292","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular signatures of concurrent mutations in drug resistant Mycobacterium tuberculosis: Association with treatment outcomes","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101292"}}